BioCentury | Apr 21, 2014
Clinical News

Teriparatide nasal spray: Phase I started

...open-label, U.K. Phase I trial to compare single doses of 22.5, 45 and 90 µg CP046...
...to treat osteoporosis in postmenopausal women. Critical Pharmaceuticals Ltd. , Nottingham, U.K. Product: Teriparatide nasal spray ( CP046...
Items per page:
1 - 1 of 1